Abstract:Cerebral small vessel disease (SVD) causes lacunar stroke and intracerebral hemorrhage, and is the most common pathology underlying vascular cognitive impairment. Increasingly, the importance of other clinical features of SVD is being recognized including motor impairment, (vascular) parkinsonism, impaired balance, falls, and behavioral symptoms, such as depression, apathy, and personality change. Epidemiological data show a high prevalence of the characteristic magnetic resonance imaging (MRI) features of white matter hyperintensities and lacunar infarcts in community studies, and recent data suggest that it is also a major health burden in low- and middle-income countries. In this review, we cover advances in diagnosis, imaging, clinical presentations, pathogenesis, and treatment.The two most common pathologies underlying SVD are arteriolosclerosis caused by aging, hypertension, and other conventional vascular risk factors, and cerebral amyloid angiopathy (CAA) caused by vascular deposition of β-amyloid. We discuss the revised Boston criteria of CAA based on MRI features, which have been recently validated. Imaging is providing important insights into pathogenesis, including improved detection of tissue damage using diffusion tensor imaging (DTI) leading to its use to monitor progression and surrogate endpoints in clinical trials. Advanced MRI techniques can demonstrate functional or dynamic abnormalities of the blood vessels, while the high spatial resolution provided by ultrahigh field MRI at 7 T allows imaging of individual perforating arteries for the first time, and the measurement of flow velocity and pulsatility within these arteries. DTI and structural network analysis have highlighted the importance of network disruption in mediating the effect of different SVD pathologies in causing a number of symptoms, including cognitive impairment, apathy, and gait disturbance.Despite the public health importance of SVD, there are few proven treatments. We review the evidence for primary prevention, and recent data showing how intensive blood pressure lowering reduces white matter hyperintensities (WMH) progression and delays the onset of cognitive impairment. There are few treatments for secondary prevention, but a number of trials are currently evaluating novel treatment approaches. Recent advances have implicated molecular processes related to endothelial dysfunction, nitric oxide synthesis, blood-brain barrier integrity, maintenance and repair of the extracellular matrix, and inflammation. Novel treatment approaches are being developed to a number of these targets. Finally, we highlight the importance of large International collaborative initiatives in SVD to address important research questions and cover a number which have recently been established.

Cerebral small vessel disease and stroke: Linked by stroke aetiology, but not stroke lesion location or size

Small vessel disease and clinical outcomes after IV rt-PA treatment

Incident Infarcts in Patients With Stroke and Cerebral Small Vessel Disease: Frequency and Relation to Clinical Outcomes

Small Vessel Disease Burden and Prognosis of Recent Subcortical Ischaemic Stroke Differ by Parent Artery Atherosclerosis.

Cerebral small vessel disease: Recent advances and future directions

Effect of Cerebral Small Vessel Disease Burden on Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment

Extracranial Artery Stenosis is Associated with Total MRI Burden of Cerebral Small Vessel Disease in Ischemic Stroke Patients of Suspected Small or Large Artery Origins

Higher burden of cerebral small vessel disease associated with risk of incident stroke in community dwelling individuals

Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden

Reduced Coupling Between the Global Blood-Oxygen-level-dependent Signal and Cerebrospinal Fluid Inflow is Associated with the Severity of Small Vessel Disease.

The analysis of association between single features of small vessel disease and stroke outcome shows the independent impact of the number of microbleeds and presence of lacunes

Associations Between Carotid Plaques and White Matter Hyperintensities in Cerebral Small Vessel Disease

Total MRI Burden of Cerebral Vessel Disease Correlates with the Progression in Patients with Acute Single Small Subcortical Strokes

Cerebral small vessel disease is an independent determinant of dysphagia after acute stroke

Correlations in post-mortem imaging-histopathology studies of sporadic human cerebral small vessel disease: A systematic review

Network Localisation of White Matter Damage in Cerebral Small Vessel Disease

Abstract WMP22: Higher Burden of Cerebral Small Vessel Disease is Associated With Risk of Incident Stroke in Community-Dwelling Individuals

Carotid artery stenosis is related to cerebral small vessel disease magnetic resonance imaging burden

Correlation Study Between Small Vessel Disease and Early Neurological Deterioration in Patients with Mild/moderate Acute Ischemic Stroke

Modified Cerebral Small Vessel Disease Score is Associated with Vascular Cognitive Impairment after Lacunar Stroke

Associations of Cerebral Small Vessel Disease and Chronic Kidney Disease in Patients With Acute Intracerebral Hemorrhage